Curation OPDM4 RILPL1
7.5 + 2.5 = 10 / 18
Genetic evidence
Total: 7.5
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | In a 94-case Chinese OPDM cohort, 11 individuals were reported with RILPL1 CGG/GGC repeat expansions (OPDM4) after screening known OPDM repeat loci; the paper provides cohort-level support rather than detailed new RILPL1 proband descriptions. | |
Collective Evidence | Segregation | 1.5 | Parametric linkage analysis in Family 1 mapped disease to 12q24.3 with a maximum LOD score of 2.4007; RILPL1 GGC expansion was identified within the linked interval, tracked with affected relatives, and shared haplotype data supported a founder effect across families. |
Experimental evidence
Total: 2.5
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Function | Protein interaction | 1 | In OPDM4 patient muscle, immunofluorescence showed glycine/polyG signal co-localized with p62 in intranuclear inclusions, consistent with repeat-associated polyG protein aggregation; the paper also notes gene-level RILPL1/RAB10 interaction biology. | |
Function | Regulatory impact | 0.5 | Targeted methylation showed hypermethylation at the RILPL1 locus in unaffected ultralong expansion carriers, while OPDM4 patient muscle showed no significant RILPL1 mRNA or protein change; CAGE-seq and strand-specific RNA-seq supported alternative/antisense TSSs and bidirectional transcription across the repeat locus. | |
Functional Alteration | Patient cells | 1 | Patient muscle biopsies showed rimmed vacuoles and intranuclear filamentous inclusions; RNA FISH/immunofluorescence showed expanded RILPL1 RNA foci co-localized with MBNL1 and p62 in intranuclear inclusions in OPDM4 muscle but not control muscle. |